Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | TLR2 | O60603 | 5/20 | 0.48 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 6/20 | 0.48 |
| ▸ | KLK7 | P49862 | 1/20 | 0.41 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30895554 | 1.00 | KMT2A (0.51) | KMT2ATLR2TLR1MDM2KLK7 | |
| SCHEMBL30895422 | 0.98 | KMT2A (0.49) | KMT2ATLR2TLR1MDM2 | |
| SCHEMBL30895559 | 0.94 | TLR2 (0.51) | KMT2ATLR2TLR1MDM2KLK7 | |
| SCHEMBL30895488 | 0.94 | TLR2 (0.52) | KMT2ATLR2TLR1MDM2 | |
| SCHEMBL32670249 | 0.94 | TLR2 (0.52) | KMT2ATLR2TLR1MDM2 | |
| SCHEMBL34469052 | 0.94 | TLR2 (0.52) | KMT2ATLR2TLR1MDM2 | |
| SCHEMBL30895547 | 0.94 | TLR2 (0.52) | KMT2ATLR2TLR1MDM2 | |
| SCHEMBL20561672 | 0.94 | TLR2 (0.52) | KMT2ATLR2TLR1MDM2 | |
| SCHEMBL20561674 | 0.94 | TLR2 (0.52) | KMT2ATLR2TLR1MDM2 | |
| SCHEMBL29985390 | 0.94 | TLR2 (0.52) | KMT2ATLR2TLR1MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608451-A1 | CD70 ANTIBODY DRUG CONJUGATES AND METHODS OF USING THE SAME | Genmab A/S (DK) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024092067-A1 | CD70 ANTIBODY DRUG CONJUGATES AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-05-02 | — | — | WO | disclosed |